WINDTREE THERAPEUTICS INC /DE/ (WINT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 700K 1.4M 2.1M FY15: 987K FY16: 2M FY17: 1.5M FY18: 1.8M FY19: 198K FY15 FY16 FY17 FY18 FY19

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

-90M -60M -30M 0 30M 60M 90M FY20: -30.3M FY21: -77.3M FY22: -41.3M FY23: -20.6M FY24: -26.1M FY20 FY21 FY22 FY23 FY24

Net Income Annual

-75M -50M -25M 0 25M 50M 75M FY20: -32.6M FY21: -67.6M FY22: -39.2M FY23: -20.3M FY24: -1.8M FY20 FY21 FY22 FY23 FY24

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-27M -18M -9M 0 9M 18M 27M FY20: -25.3M FY21: -23.7M FY22: -19.5M FY23: -13.4M FY24: -15.4M FY20 FY21 FY22 FY23 FY24

Free Cash Flow Annual

-27M -18M -9M 0 9M 18M 27M FY20: -25.6M FY21: -23.9M FY22: -19.5M FY23: -13.5M FY24: -15.4M FY20 FY21 FY22 FY23 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20M 40M 60M FY18: 4.5M FY21: 495K FY22: 630K FY23: 4.3M FY24: 52.6M FY18 FY21 FY22 FY23 FY24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6000.00 -4000.00 -2000.00 0.00 2000.00 4000.00 6000.00 Q1 '19: -5.70 Q2 '19: -5.49 Q3 '19: -5.11 Q4 '19: -2.08 Q1 '20: -1.95 Q2 '20: -1.98 Q3 '20: -1.86 Q4 '20: -2.08 Q1 '21: -2.11 Q2 '21: -2.90 Q3 '21: -2.67 Q4 '21: -2.66 Q1 '22: -16.51 Q2 '22: -44.77 Q3 '22: -50.97 Q4 '22: -62.84 Q1 '23: -134.13 Q2 '23: -133.92 Q3 '23: -142.88 Q4 '23: -4768.48 Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.